Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT02276820
What this trial is testing

Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)

Who this might be right for
Adenovirus Infection
AlloVir
Large-scale testing (Phase 3)Ended earlyNCT03870750
What this trial is testing

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmNon-Neoplastic Hematologic and Lymphocytic Disorder
Fred Hutchinson Cancer Center 458
Testing effectiveness (Phase 2)Looking for participantsNCT06783790
What this trial is testing

Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT

Who this might be right for
AML (Acute Myelogenous Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableUnknownNCT06241274
What this trial is testing

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Who this might be right for
MoxibustionHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Not applicableNot Yet RecruitingNCT06582797
What this trial is testing

Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor

Who this might be right for
HIV-1-infection
University of Kansas Medical Center 10
Not applicableStudy completedNCT04506320
What this trial is testing

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaStem Cell Transplant
Gruppo Italiano Trapianto di Midollo Osseo 202
Large-scale testing (Phase 3)Study completedNCT00557817
What this trial is testing

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Hematological Malignancies
University of Liege 125
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075238
What this trial is testing

Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT

Who this might be right for
Leukemia, Lymphoid
Sichuan University 68
Testing effectiveness (Phase 2)Study completedNCT01527045
What this trial is testing

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Aggressive Non-Hodgkin LymphomaBlasts Under 5 Percent of Bone Marrow Nucleated CellsChronic Lymphocytic Leukemia+18 more
Fred Hutchinson Cancer Center 47
Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07774377
What this trial is testing

Chidamide Maintenance to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute T-Lymphoblastic Leukemia/Lymphoma

Who this might be right for
T-Cell Acute Lymphoblastic LeukemiaT-Cell Lymphoblastic Lymphoma
First Affiliated Hospital of Zhejiang University 132
Large-scale testing (Phase 3)Looking for participantsNCT07366801
What this trial is testing

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia, RelapsedAcute Lymphoblastic Leukemia, High RiskAcute Myeloid Leukemia, High Risk+1 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Not applicableNo Longer AvailableNCT02822495
What this trial is testing

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Who this might be right for
Epstein-Barr Virus (EBV) InfectionsLymphoproliferative DisordersEBV+ Associated Lymphoma+9 more
Atara Biotherapeutics
Not applicableStudy completedNCT02577939
What this trial is testing

Evaluation of Cardiorespiratory Performance After Interval Exercise Training Prior to Hematopoietic Cell Transplantation

Who this might be right for
Stem Cell Transplantation, Hematopoietic
UNC Lineberger Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT03082677
What this trial is testing

Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies

Who this might be right for
Myeloid Hematologic MalignancyLymphoid Hematologic Malignancy
Memorial Sloan Kettering Cancer Center 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07588945
What this trial is testing

DaGOAT-Guided Prevention of Severe aGVHD After Allo-HSCT

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 438
Not applicableUnknownNCT04051372
What this trial is testing

Diagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL

Who this might be right for
Bronchoalveolar Lavage FluidLung Infection
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 250
Early research (Phase 1)Active Not RecruitingNCT05233618
What this trial is testing

Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)

Who this might be right for
MyelofibrosisChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Karen Ballen, MD 44
Testing effectiveness (Phase 2)Ended earlyNCT03720392
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)
Zachariah Michael DeFilipp 8
Large-scale testing (Phase 3)Looking for participantsNCT04314219
What this trial is testing

Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia (ALL) in Complete RemissionAcute Myeloid Leukemia (AML) in Remission
King Faisal Specialist Hospital & Research Center 264
Next Page
64